img

Global Nuclear Receptor ROR Gamma Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nuclear Receptor ROR Gamma Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Nuclear Receptor ROR Gamma report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nuclear Receptor ROR Gamma market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Obstructive Pulmonary Disease and Asthma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nuclear Receptor ROR Gamma industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nuclear Receptor ROR Gamma key manufacturers include Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc and Pfizer Inc, etc. Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies are top 3 players and held % sales share in total in 2022.
Nuclear Receptor ROR Gamma can be divided into BBI-6000, GRC-39815Action, R&D Progress and GSK-2981278, etc. BBI-6000 is the mainstream product in the market, accounting for % sales share globally in 2022.
Nuclear Receptor ROR Gamma is widely used in various fields, such as Chronic Obstructive Pulmonary Disease, Asthma, Axial Spondyloarthritis and Breast Cancer, etc. Chronic Obstructive Pulmonary Disease provides greatest supports to the Nuclear Receptor ROR Gamma industry development. In 2022, global % sales of Nuclear Receptor ROR Gamma went into Chronic Obstructive Pulmonary Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nuclear Receptor ROR Gamma market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Genfit SA
GlaxoSmithKline Plc
Aurigene Discovery Technologies
Beijing Hanmi Pharmaceutical
Biogen Inc
AbbVie Inc
Eurofins Advinus
Brickell Biotech Inc
Pfizer Inc
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc
Bristol-Myers Squibb Company
Celgene Corp
Eli Lilly
Glenmark Pharmaceuticals
Lead Pharma Holding BV
Segment by Type
BBI-6000
GRC-39815Action
R&D Progress
GSK-2981278
IMU-366
INV-17
Others

Segment by Application


Chronic Obstructive Pulmonary Disease
Asthma
Axial Spondyloarthritis
Breast Cancer
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nuclear Receptor ROR Gamma market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nuclear Receptor ROR Gamma, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nuclear Receptor ROR Gamma industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nuclear Receptor ROR Gamma in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nuclear Receptor ROR Gamma introduction, etc. Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Nuclear Receptor ROR Gamma market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Nuclear Receptor ROR Gamma Market Overview
1.1 Nuclear Receptor ROR Gamma Product Overview
1.2 Nuclear Receptor ROR Gamma Market Segment by Type
1.2.1 BBI-6000
1.2.2 GRC-39815Action
1.2.3 R&D Progress
1.2.4 GSK-2981278
1.2.5 IMU-366
1.2.6 INV-17
1.2.7 Others
1.3 Global Nuclear Receptor ROR Gamma Market Size by Type
1.3.1 Global Nuclear Receptor ROR Gamma Market Size Overview by Type (2018-2034)
1.3.2 Global Nuclear Receptor ROR Gamma Historic Market Size Review by Type (2018-2024)
1.3.3 Global Nuclear Receptor ROR Gamma Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nuclear Receptor ROR Gamma Sales Breakdown by Type (2018-2024)
1.4.2 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Nuclear Receptor ROR Gamma Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Nuclear Receptor ROR Gamma Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Nuclear Receptor ROR Gamma Sales Breakdown by Type (2018-2024)
2 Global Nuclear Receptor ROR Gamma Market Competition by Company
2.1 Global Top Players by Nuclear Receptor ROR Gamma Sales (2018-2024)
2.2 Global Top Players by Nuclear Receptor ROR Gamma Revenue (2018-2024)
2.3 Global Top Players by Nuclear Receptor ROR Gamma Price (2018-2024)
2.4 Global Top Manufacturers Nuclear Receptor ROR Gamma Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nuclear Receptor ROR Gamma Market Competitive Situation and Trends
2.5.1 Nuclear Receptor ROR Gamma Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nuclear Receptor ROR Gamma Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Receptor ROR Gamma as of 2022)
2.7 Date of Key Manufacturers Enter into Nuclear Receptor ROR Gamma Market
2.8 Key Manufacturers Nuclear Receptor ROR Gamma Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nuclear Receptor ROR Gamma Status and Outlook by Region
3.1 Global Nuclear Receptor ROR Gamma Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Nuclear Receptor ROR Gamma Historic Market Size by Region
3.2.1 Global Nuclear Receptor ROR Gamma Sales in Volume by Region (2018-2024)
3.2.2 Global Nuclear Receptor ROR Gamma Sales in Value by Region (2018-2024)
3.2.3 Global Nuclear Receptor ROR Gamma Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Nuclear Receptor ROR Gamma Forecasted Market Size by Region
3.3.1 Global Nuclear Receptor ROR Gamma Sales in Volume by Region (2024-2034)
3.3.2 Global Nuclear Receptor ROR Gamma Sales in Value by Region (2024-2034)
3.3.3 Global Nuclear Receptor ROR Gamma Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Nuclear Receptor ROR Gamma by Application
4.1 Nuclear Receptor ROR Gamma Market Segment by Application
4.1.1 Chronic Obstructive Pulmonary Disease
4.1.2 Asthma
4.1.3 Axial Spondyloarthritis
4.1.4 Breast Cancer
4.1.5 Others
4.2 Global Nuclear Receptor ROR Gamma Market Size by Application
4.2.1 Global Nuclear Receptor ROR Gamma Market Size Overview by Application (2018-2034)
4.2.2 Global Nuclear Receptor ROR Gamma Historic Market Size Review by Application (2018-2024)
4.2.3 Global Nuclear Receptor ROR Gamma Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nuclear Receptor ROR Gamma Sales Breakdown by Application (2018-2024)
4.3.2 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Nuclear Receptor ROR Gamma Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Nuclear Receptor ROR Gamma Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Nuclear Receptor ROR Gamma Sales Breakdown by Application (2018-2024)
5 North America Nuclear Receptor ROR Gamma by Country
5.1 North America Nuclear Receptor ROR Gamma Historic Market Size by Country
5.1.1 North America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Nuclear Receptor ROR Gamma Sales in Volume by Country (2018-2024)
5.1.3 North America Nuclear Receptor ROR Gamma Sales in Value by Country (2018-2024)
5.2 North America Nuclear Receptor ROR Gamma Forecasted Market Size by Country
5.2.1 North America Nuclear Receptor ROR Gamma Sales in Volume by Country (2024-2034)
5.2.2 North America Nuclear Receptor ROR Gamma Sales in Value by Country (2024-2034)
6 Europe Nuclear Receptor ROR Gamma by Country
6.1 Europe Nuclear Receptor ROR Gamma Historic Market Size by Country
6.1.1 Europe Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Nuclear Receptor ROR Gamma Sales in Volume by Country (2018-2024)
6.1.3 Europe Nuclear Receptor ROR Gamma Sales in Value by Country (2018-2024)
6.2 Europe Nuclear Receptor ROR Gamma Forecasted Market Size by Country
6.2.1 Europe Nuclear Receptor ROR Gamma Sales in Volume by Country (2024-2034)
6.2.2 Europe Nuclear Receptor ROR Gamma Sales in Value by Country (2024-2034)
7 Asia-Pacific Nuclear Receptor ROR Gamma by Region
7.1 Asia-Pacific Nuclear Receptor ROR Gamma Historic Market Size by Region
7.1.1 Asia-Pacific Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Nuclear Receptor ROR Gamma Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Nuclear Receptor ROR Gamma Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Nuclear Receptor ROR Gamma Forecasted Market Size by Region
7.2.1 Asia-Pacific Nuclear Receptor ROR Gamma Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Nuclear Receptor ROR Gamma Sales in Value by Region (2024-2034)
8 Latin America Nuclear Receptor ROR Gamma by Country
8.1 Latin America Nuclear Receptor ROR Gamma Historic Market Size by Country
8.1.1 Latin America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Nuclear Receptor ROR Gamma Sales in Volume by Country (2018-2024)
8.1.3 Latin America Nuclear Receptor ROR Gamma Sales in Value by Country (2018-2024)
8.2 Latin America Nuclear Receptor ROR Gamma Forecasted Market Size by Country
8.2.1 Latin America Nuclear Receptor ROR Gamma Sales in Volume by Country (2024-2034)
8.2.2 Latin America Nuclear Receptor ROR Gamma Sales in Value by Country (2024-2034)
9 Middle East and Africa Nuclear Receptor ROR Gamma by Country
9.1 Middle East and Africa Nuclear Receptor ROR Gamma Historic Market Size by Country
9.1.1 Middle East and Africa Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Nuclear Receptor ROR Gamma Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Nuclear Receptor ROR Gamma Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Nuclear Receptor ROR Gamma Forecasted Market Size by Country
9.2.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Nuclear Receptor ROR Gamma Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Genfit SA
10.1.1 Genfit SA Company Information
10.1.2 Genfit SA Introduction and Business Overview
10.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Genfit SA Nuclear Receptor ROR Gamma Products Offered
10.1.5 Genfit SA Recent Development
10.2 GlaxoSmithKline Plc
10.2.1 GlaxoSmithKline Plc Company Information
10.2.2 GlaxoSmithKline Plc Introduction and Business Overview
10.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Products Offered
10.2.5 GlaxoSmithKline Plc Recent Development
10.3 Aurigene Discovery Technologies
10.3.1 Aurigene Discovery Technologies Company Information
10.3.2 Aurigene Discovery Technologies Introduction and Business Overview
10.3.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Products Offered
10.3.5 Aurigene Discovery Technologies Recent Development
10.4 Beijing Hanmi Pharmaceutical
10.4.1 Beijing Hanmi Pharmaceutical Company Information
10.4.2 Beijing Hanmi Pharmaceutical Introduction and Business Overview
10.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Products Offered
10.4.5 Beijing Hanmi Pharmaceutical Recent Development
10.5 Biogen Inc
10.5.1 Biogen Inc Company Information
10.5.2 Biogen Inc Introduction and Business Overview
10.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biogen Inc Nuclear Receptor ROR Gamma Products Offered
10.5.5 Biogen Inc Recent Development
10.6 AbbVie Inc
10.6.1 AbbVie Inc Company Information
10.6.2 AbbVie Inc Introduction and Business Overview
10.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Products Offered
10.6.5 AbbVie Inc Recent Development
10.7 Eurofins Advinus
10.7.1 Eurofins Advinus Company Information
10.7.2 Eurofins Advinus Introduction and Business Overview
10.7.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Eurofins Advinus Nuclear Receptor ROR Gamma Products Offered
10.7.5 Eurofins Advinus Recent Development
10.8 Brickell Biotech Inc
10.8.1 Brickell Biotech Inc Company Information
10.8.2 Brickell Biotech Inc Introduction and Business Overview
10.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Products Offered
10.8.5 Brickell Biotech Inc Recent Development
10.9 Pfizer Inc
10.9.1 Pfizer Inc Company Information
10.9.2 Pfizer Inc Introduction and Business Overview
10.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Products Offered
10.9.5 Pfizer Inc Recent Development
10.10 Phenex Pharmaceuticals AG
10.10.1 Phenex Pharmaceuticals AG Company Information
10.10.2 Phenex Pharmaceuticals AG Introduction and Business Overview
10.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Products Offered
10.10.5 Phenex Pharmaceuticals AG Recent Development
10.11 Reata Pharmaceuticals Inc
10.11.1 Reata Pharmaceuticals Inc Company Information
10.11.2 Reata Pharmaceuticals Inc Introduction and Business Overview
10.11.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Products Offered
10.11.5 Reata Pharmaceuticals Inc Recent Development
10.12 Bristol-Myers Squibb Company
10.12.1 Bristol-Myers Squibb Company Company Information
10.12.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.12.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Products Offered
10.12.5 Bristol-Myers Squibb Company Recent Development
10.13 Celgene Corp
10.13.1 Celgene Corp Company Information
10.13.2 Celgene Corp Introduction and Business Overview
10.13.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Celgene Corp Nuclear Receptor ROR Gamma Products Offered
10.13.5 Celgene Corp Recent Development
10.14 Eli Lilly
10.14.1 Eli Lilly Company Information
10.14.2 Eli Lilly Introduction and Business Overview
10.14.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Eli Lilly Nuclear Receptor ROR Gamma Products Offered
10.14.5 Eli Lilly Recent Development
10.15 Glenmark Pharmaceuticals
10.15.1 Glenmark Pharmaceuticals Company Information
10.15.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.15.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Products Offered
10.15.5 Glenmark Pharmaceuticals Recent Development
10.16 Lead Pharma Holding BV
10.16.1 Lead Pharma Holding BV Company Information
10.16.2 Lead Pharma Holding BV Introduction and Business Overview
10.16.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Products Offered
10.16.5 Lead Pharma Holding BV Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nuclear Receptor ROR Gamma Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nuclear Receptor ROR Gamma Industrial Chain Analysis
11.4 Nuclear Receptor ROR Gamma Market Dynamics
11.4.1 Nuclear Receptor ROR Gamma Industry Trends
11.4.2 Nuclear Receptor ROR Gamma Market Drivers
11.4.3 Nuclear Receptor ROR Gamma Market Challenges
11.4.4 Nuclear Receptor ROR Gamma Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nuclear Receptor ROR Gamma Distributors
12.3 Nuclear Receptor ROR Gamma Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of BBI-6000
Table 2. Major Company of GRC-39815Action
Table 3. Major Company of R&D Progress
Table 4. Major Company of GSK-2981278
Table 5. Major Company of IMU-366
Table 6. Major Company of INV-17
Table 7. Major Company of Others
Table 8. Global Nuclear Receptor ROR Gamma Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (K Pcs)
Table 10. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (US& Million)
Table 12. Global Nuclear Receptor ROR Gamma Market Share in Value by Type (2018-2024)
Table 13. Global Nuclear Receptor ROR Gamma Price by Type (2018-2024) & (USD/Pcs)
Table 14. Global Nuclear Receptor ROR Gamma Sales by Type (2024-2034) & (K Pcs)
Table 15. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Nuclear Receptor ROR Gamma Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Type (2024-2034)
Table 18. Global Nuclear Receptor ROR Gamma Price by Type (2024-2034) & (USD/Pcs)
Table 19. North America Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (K Pcs)
Table 20. North America Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2018-2024)
Table 22. Europe Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2018-2024)
Table 24. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2018-2024)
Table 26. Latin America Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2018-2024)
Table 28. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Nuclear Receptor ROR Gamma Sales by Company (2018-2024) & (K Pcs)
Table 30. Global Nuclear Receptor ROR Gamma Sales Share by Company (2018-2024)
Table 31. Global Nuclear Receptor ROR Gamma Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Nuclear Receptor ROR Gamma Revenue Share by Company (2018-2024)
Table 33. Global Market Nuclear Receptor ROR Gamma Price by Company (2018-2024) & (USD/Pcs)
Table 34. Global Nuclear Receptor ROR Gamma Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Nuclear Receptor ROR Gamma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Receptor ROR Gamma as of 2022)
Table 37. Date of Key Manufacturers Enter into Nuclear Receptor ROR Gamma Market
Table 38. Key Manufacturers Nuclear Receptor ROR Gamma Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Nuclear Receptor ROR Gamma Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Nuclear Receptor ROR Gamma Sales by Region (2018-2024) & (K Pcs)
Table 42. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Nuclear Receptor ROR Gamma Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Region (2018-2024)
Table 45. Global Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 46. Global Nuclear Receptor ROR Gamma Sales by Region (2024-2034) & (K Pcs)
Table 47. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Nuclear Receptor ROR Gamma Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Region (2024-2034)
Table 50. Global Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 51. Global Nuclear Receptor ROR Gamma Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (K Pcs)
Table 53. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Application (2018-2024)
Table 56. Global Nuclear Receptor ROR Gamma Price by Application (2018-2024) & (USD/Pcs)
Table 57. Global Nuclear Receptor ROR Gamma Sales by Application (2024-2034) & (K Pcs)
Table 58. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Nuclear Receptor ROR Gamma Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Application (2024-2034)
Table 61. Global Nuclear Receptor ROR Gamma Price by Application (2024-2034) & (USD/Pcs)
Table 62. North America Nuclear Receptor ROR Gamma Sales by Application (2018-2024) (K Pcs)
Table 63. North America Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Nuclear Receptor ROR Gamma Sales by Application (2018-2024) (K Pcs)
Table 65. Europe Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Application (2018-2024) (K Pcs)
Table 67. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Nuclear Receptor ROR Gamma Sales by Application (2018-2024) (K Pcs)
Table 69. Latin America Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Application (2018-2024) (K Pcs)
Table 71. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (K Pcs)
Table 73. North America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2018-2024)
Table 76. North America Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (K Pcs)
Table 77. North America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (K Pcs)
Table 81. Europe Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (K Pcs)
Table 85. Europe Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Region (2018-2024) & (K Pcs)
Table 89. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Region (2024-2034) & (K Pcs)
Table 93. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (K Pcs)
Table 97. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (K Pcs)
Table 101. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (K Pcs)
Table 105. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (K Pcs)
Table 109. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Value by Country (2024-2034)
Table 112. Genfit SA Company Information
Table 113. Genfit SA Introduction and Business Overview
Table 114. Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Genfit SA Nuclear Receptor ROR Gamma Product
Table 116. Genfit SA Recent Development
Table 117. GlaxoSmithKline Plc Company Information
Table 118. GlaxoSmithKline Plc Introduction and Business Overview
Table 119. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product
Table 121. GlaxoSmithKline Plc Recent Development
Table 122. Aurigene Discovery Technologies Company Information
Table 123. Aurigene Discovery Technologies Introduction and Business Overview
Table 124. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product
Table 126. Aurigene Discovery Technologies Recent Development
Table 127. Beijing Hanmi Pharmaceutical Company Information
Table 128. Beijing Hanmi Pharmaceutical Introduction and Business Overview
Table 129. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product
Table 131. Beijing Hanmi Pharmaceutical Recent Development
Table 132. Biogen Inc Company Information
Table 133. Biogen Inc Introduction and Business Overview
Table 134. Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Biogen Inc Nuclear Receptor ROR Gamma Product
Table 136. Biogen Inc Recent Development
Table 137. AbbVie Inc Company Information
Table 138. AbbVie Inc Introduction and Business Overview
Table 139. AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. AbbVie Inc Nuclear Receptor ROR Gamma Product
Table 141. AbbVie Inc Recent Development
Table 142. Eurofins Advinus Company Information
Table 143. Eurofins Advinus Introduction and Business Overview
Table 144. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Eurofins Advinus Nuclear Receptor ROR Gamma Product
Table 146. Eurofins Advinus Recent Development
Table 147. Brickell Biotech Inc Company Information
Table 148. Brickell Biotech Inc Introduction and Business Overview
Table 149. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product
Table 151. Brickell Biotech Inc Recent Development
Table 152. Pfizer Inc Company Information
Table 153. Pfizer Inc Introduction and Business Overview
Table 154. Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Pfizer Inc Nuclear Receptor ROR Gamma Product
Table 156. Pfizer Inc Recent Development
Table 157. Phenex Pharmaceuticals AG Company Information
Table 158. Phenex Pharmaceuticals AG Introduction and Business Overview
Table 159. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product
Table 161. Phenex Pharmaceuticals AG Recent Development
Table 162. Reata Pharmaceuticals Inc Company Information
Table 163. Reata Pharmaceuticals Inc Introduction and Business Overview
Table 164. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product
Table 166. Reata Pharmaceuticals Inc Recent Development
Table 167. Bristol-Myers Squibb Company Company Information
Table 168. Bristol-Myers Squibb Company Introduction and Business Overview
Table 169. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product
Table 171. Bristol-Myers Squibb Company Recent Development
Table 172. Celgene Corp Company Information
Table 173. Celgene Corp Introduction and Business Overview
Table 174. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 175. Celgene Corp Nuclear Receptor ROR Gamma Product
Table 176. Celgene Corp Recent Development
Table 177. Eli Lilly Company Information
Table 178. Eli Lilly Introduction and Business Overview
Table 179. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Eli Lilly Nuclear Receptor ROR Gamma Product
Table 181. Eli Lilly Recent Development
Table 182. Glenmark Pharmaceuticals Company Information
Table 183. Glenmark Pharmaceuticals Introduction and Business Overview
Table 184. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 185. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product
Table 186. Glenmark Pharmaceuticals Recent Development
Table 187. Lead Pharma Holding BV Company Information
Table 188. Lead Pharma Holding BV Introduction and Business Overview
Table 189. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 190. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product
Table 191. Lead Pharma Holding BV Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Nuclear Receptor ROR Gamma Market Trends
Table 195. Nuclear Receptor ROR Gamma Market Drivers
Table 196. Nuclear Receptor ROR Gamma Market Challenges
Table 197. Nuclear Receptor ROR Gamma Market Restraints
Table 198. Nuclear Receptor ROR Gamma Distributors List
Table 199. Nuclear Receptor ROR Gamma Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Receptor ROR Gamma Product Picture
Figure 2. Global Nuclear Receptor ROR Gamma Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nuclear Receptor ROR Gamma Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Nuclear Receptor ROR Gamma Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of BBI-6000
Figure 6. Global BBI-6000 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of GRC-39815Action
Figure 8. Global GRC-39815Action Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of R&D Progress
Figure 10. Global R&D Progress Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of GSK-2981278
Figure 12. Global GSK-2981278 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of IMU-366
Figure 14. Global IMU-366 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of INV-17
Figure 16. Global INV-17 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 19. Global Nuclear Receptor ROR Gamma Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Nuclear Receptor ROR Gamma Sales Market Share by Type in 2022 & 2034
Figure 21. North America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2022
Figure 22. North America Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2022
Figure 23. Europe Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2022
Figure 24. Europe Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2022
Figure 27. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Receptor ROR Gamma Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Receptor ROR Gamma Revenue in 2022
Figure 33. Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Chronic Obstructive Pulmonary Disease
Figure 35. Global Chronic Obstructive Pulmonary Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Asthma
Figure 37. Global Asthma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Axial Spondyloarthritis
Figure 39. Global Axial Spondyloarthritis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Breast Cancer
Figure 41. Global Breast Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Product Picture of Others
Figure 43. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 44. Global Nuclear Receptor ROR Gamma Sales by Application (2018-2034) & (US$ Million)
Figure 45. Global Nuclear Receptor ROR Gamma Sales Market Share by Application in 2022 & 2034
Figure 46. North America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2022
Figure 47. North America Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2022
Figure 48. Europe Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2022
Figure 49. Europe Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2022
Figure 52. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2022
Figure 53. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. Nuclear Receptor ROR Gamma Manufacturing Cost Structure
Figure 57. Nuclear Receptor ROR Gamma Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries